Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L McGovern

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Current Oncology Reports|April 26, 2012
Progress in radiotherapy for pediatric sarcomasSusan L McGovern, Anita Mahajan
Journal of Medicinal Chemistry|June 27, 2003
Information decay in molecular docking screens against holo, apo, and modeled conformations of enzymesSusan L McGovern, Brian K Shoichet
Journal of Medicinal Chemistry|April 4, 2003
Kinase inhibitors: not just for kinases anymoreSusan L McGovern, Brian K Shoichet
Frontiers in Oncology|May 22, 2023
Proton therapy for pediatric diencephalic tumorsAdam J Grippin, Susan L McGovern
Cancer Journal (Sudbury, Mass.)|November 22, 2014
Embryonal brain tumorsSusan L McGovern, David Grosshans, Anita Mahajan
Journal of Medicinal Chemistry|April 5, 2002
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screeningSusan L McGovern, Emilia Caselli, Nikolaus Grigorieff, et al.
Advances in Radiation Oncology|March 21, 2018
Obsessive-compulsive disorder after therapy for an optic pathway gliomaDiana Guzman, Eeva Edds, Soumen Khatua, et al.
Current Opinion in Chemical Biology|July 23, 2002
Lead discovery using molecular dockingBrian K Shoichet, Susan L McGovern, Binqing Wei, et al.
Journal of Medicinal Chemistry|October 3, 2003
Identification and prediction of promiscuous aggregating inhibitors among known drugsJames Seidler, Susan L McGovern, Thompson N Doman, et al.
Journal of Medicinal Chemistry|September 19, 2003
A specific mechanism of nonspecific inhibitionSusan L McGovern, Brian T Helfand, Brian Feng, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Current Oncology Reports|April 26, 2012
Progress in radiotherapy for pediatric sarcomasSusan L McGovern, Anita Mahajan
Journal of Medicinal Chemistry|June 27, 2003
Information decay in molecular docking screens against holo, apo, and modeled conformations of enzymesSusan L McGovern, Brian K Shoichet
Journal of Medicinal Chemistry|April 4, 2003
Kinase inhibitors: not just for kinases anymoreSusan L McGovern, Brian K Shoichet
Frontiers in Oncology|May 22, 2023
Proton therapy for pediatric diencephalic tumorsAdam J Grippin, Susan L McGovern
Cancer Journal (Sudbury, Mass.)|November 22, 2014
Embryonal brain tumorsSusan L McGovern, David Grosshans, Anita Mahajan
Journal of Medicinal Chemistry|April 5, 2002
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screeningSusan L McGovern, Emilia Caselli, Nikolaus Grigorieff, et al.
Advances in Radiation Oncology|March 21, 2018
Obsessive-compulsive disorder after therapy for an optic pathway gliomaDiana Guzman, Eeva Edds, Soumen Khatua, et al.
Current Opinion in Chemical Biology|July 23, 2002
Lead discovery using molecular dockingBrian K Shoichet, Susan L McGovern, Binqing Wei, et al.
Journal of Medicinal Chemistry|October 3, 2003
Identification and prediction of promiscuous aggregating inhibitors among known drugsJames Seidler, Susan L McGovern, Thompson N Doman, et al.
Journal of Medicinal Chemistry|September 19, 2003
A specific mechanism of nonspecific inhibitionSusan L McGovern, Brian T Helfand, Brian Feng, et al.
Pageof 10